Prioritize Provider Data for Seamless M&A Success

Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. The post Prioritize Provider Data for Seamless M&A Success appeared first on MedCity News.

Read More

Trump’s Return Puts Medicaid on the Chopping Block

Under President Joe Biden, enrollment in Medicaid hit a record high and the uninsured rate reached a record low. Donald Trump’s return to the White House — along with a GOP-controlled Senate and House of Representatives — is expected to change that. Republicans in Washington say they plan to use funding cuts and regulatory changes…

Read More

Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target

Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…

Read More